Ziprasidone
زیپراسیدون
🧠 Nervous SystemAtypical antipsychotic
Market / country: 🇺🇸 USA
Geodon (US)
🧮 Dose calculator
Schizophrenia · Regimen source: FDA Geodon · 2.2
- • Up to 80 mg twice daily; studied up to 100 mg twice daily. FDA Geodon · 2
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Known QT prolongation, recent MI, uncompensated heart failure, or other QT-prolonging drugs. FDA Geodon · 4
- ⚠️ Boxed warning: increased mortality in elderly patients with dementia-related psychosis. FDA Geodon · Boxed Warning
- ⛔ Not established in children. FDA Geodon · 8.4
Formulations
- 20 mg capsule — capsule 🇺🇸 USA FDA Geodon · 3
- 40 mg capsule — capsule 🇺🇸 USA FDA Geodon · 3
- 60 mg capsule — capsule 🇺🇸 USA FDA Geodon · 3
- 80 mg capsule — capsule 🇺🇸 USA FDA Geodon · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Geodon · 8.1
“Risk Summary Neonates exposed to antipsychotic drugs, including GEODON, during the third trimester are at risk for extrapyramidal and/or withdrawal symptoms following delivery (see Clinical Considerations ) .”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Geodon · 8.2
“Risk Summary Limited data from a published case report indicate the presence of ziprasidone in human milk.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Geodon · 8.4
“The safety and effectiveness of Geodon have not been established in pediatric patients.”
- 👴 Older adultsDangerous / avoid
Label: serious warning or avoid in older adults. FDA Geodon · Boxed Warning
“Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death.”
- ⚥ Females & males of reproductive potentialUse with caution
Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Geodon · 8.3
“Infertility Females Based on the pharmacologic action of ziprasidone (D2 antagonism), treatment with GEODON may result in an increase in serum prolactin levels, which may lead to a reversible reduction in fertility in females of reproductive potential [see Warnings and Precautions (5.15) and Nonclinical Toxicology …”
🔗 Reference links
- FDA (approval record)NDA020825
- DailyMed (FDA label)FDA Geodon
- MedlinePlus (NIH)ZiprasidoneZiprasidone Injection
- WHO ATC/DDDN05AE04
- Darooyab (Iran)Ziprasidone
🇮🇷 Registered in Iran Darooyab · G-1369/Ziprasidone
Dosage forms with Iranian generic codes, per Darooyab.
- 16684 · ZIPRASIDONE 40MG CAP · کپسول زیپراسیدون ۴۰ میلیگرم
- 11971 · ZIPRASYDON 20MG CAP · کپسول زیپراسیدون ۲۰ میلیگرم
- 08512 · ZIPRASYDON 20MG/ML VIAL · ویال زیپراسیدون ۲۰ میلیگرم / میلیلیتر
- 07802 · ZIPRASYDON 40MG CAP · کپسول زیپراسیدون ۴۰ میلیگرم
- 08326 · ZIPRASYDON 40MG TAB · قرص زیپراسیدون ۴۰ میلیگرم
- 08304 · ZIPRASYDON 60MG CAP · کپسول زیپراسیدون ۶۰ میلیگرم
- 07796 · ZIPRASYDON 80MG CAP · کپسول زیپراسیدون ۸۰ میلیگرم
- 52520 · ZIPRASIDONE CAPSULE ORAL 40 mg · کپسول زیپراسیدون ۴۰ میلیگرم
- 52170 · ZIPRASIDONE CAPSULE ORAL 80 mg · کپسول زیپراسیدون ۸۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Geodon · 3FDA Geodon · 2.2FDA Geodon · 2FDA Geodon · 2.3FDA Geodon · 4FDA Geodon · Boxed WarningFDA Geodon · 8.4FDA Geodon · 8.1FDA Geodon · 8.2FDA Geodon · 8.3FDA Geodon · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1369/Ziprasidone
- Clinical review⚠ Unverified